
S0887 Fecal Calprotectin as a Surrogate Marker of Clinical Remission, Clinical Response, Endoscopic Improvement, and Histo-Endoscopic Mucosal Healing: UNIFI Induction Study
Author(s) -
Brian G. Feagan,
Reena Khanna,
Colleen Marano,
Hongyan Zhang,
Bruce E. Sands
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000705596.11276.6f
Subject(s) - medicine , calprotectin , gastroenterology , receiver operating characteristic , area under the curve , clinical trial , placebo , surrogate endpoint , randomized controlled trial , surgery , pathology , alternative medicine , inflammatory bowel disease , disease